JA
Highly rated in
19
conditions
Highly rated in
19
conditions
Check Dr. John H. Ashcraft's experience treating your condition:
About Dr. John H. Ashcraft

John Ashcraft is a Colorectal Surgeon and a General Surgeon in Westwood, Kansas. Ashcraft has been practicing medicine for over 20 years and is highly rated in 19 conditions, according to our data. His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Diverticulitis, and Colorectal Cancer. He is licensed to treat patients in Kansas. Ashcraft is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. John H. Ashcraft it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. John H. Ashcraft accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Oscar

Call to see if your plan is accepted.
Locations
2650 Shawnee Mission Pkwy, Westwood, KS 66205
Other Locations
2650 Shawnee Mission Pkwy, Westwood, KS 66205
10710 Nall Ave, Overland Park, KS 66211
Background & Education
Graduate Institution
R Franklin University Of Med & Sci/chicago Medical School, 2002.0
Specialties
Colorectal Surgery
General Surgery
Licenses
Surgery in KS
Hospital Affiliations
The University Of Kansas Hospital
Ascension Via Christi Hospital In Pittsburg
Ascension Via Christi Hospital In Manhattan
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Total Publications

Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression.
Summary: Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors